Stoke Therapeutics, Inc.

NasdaqGS:STOK Stock Report

Mkt Cap: US$374.6m

Stoke Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

3.9yrs

Average management tenure


CEO

Ed Kaye (73 yo)

5.33yrs

Tenure

US$8,543,358

Compensation

Dr. Edward M. Kaye, also known as Ed, M.D., Ph.D. has been Special Regulatory and Scientific Advisor of Sarepta Therapeutics, Inc. since June 28, 2017. He serves as Independent Director at Avidity Bioscien...


CEO Compensation Analysis

How has Ed Kaye's remuneration changed compared to Stoke Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$100m

Jun 30 2022n/an/a

-US$96m

Mar 31 2022n/an/a

-US$94m

Dec 31 2021US$9mUS$568k

-US$86m

Sep 30 2021n/an/a

-US$76m

Jun 30 2021n/an/a

-US$67m

Mar 31 2021n/an/a

-US$58m

Dec 31 2020US$5mUS$549k

-US$52m

Sep 30 2020n/an/a

-US$48m

Jun 30 2020n/an/a

-US$43m

Mar 31 2020n/an/a

-US$38m

Dec 31 2019US$668kUS$477k

-US$32m

Sep 30 2019n/an/a

-US$26m

Jun 30 2019n/an/a

-US$21m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$1mUS$464k

-US$13m

Compensation vs Market: Ed's total compensation ($USD8.54M) is above average for companies of similar size in the US market ($USD2.45M).

Compensation vs Earnings: Ed's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Edward Kaye
CEO & Director5.33yrsUS$8.54m0.063%
$ 237.5k
Adrian Krainer
Co-Founderno dataUS$378.03k1.03%
$ 3.8m
Stephen Tulipano
Chief Financial Officer3.92yrsUS$3.10m0.030%
$ 111.7k
Barry Ticho
Chief Medical Officer5.33yrsUS$3.15m0.32%
$ 1.2m
Isabel Aznarez
Co-Founder & Group VP of Discovery Researchno datano datano data
Huw Nash
COO & Chief Business Officer5.33yrsUS$869.86kno data
Eric Rojas
Head of Investor Relationsno datano datano data
Jonathan Allan
General Counsel2.08yrsno datano data
Dawn Kalmar
Chief Communications Officer2.08yrsno datano data
Joan Wood
Chief Human Resources Officer3.33yrsno datano data
Shamim Ruff
Chief Regulatory Officer4.17yrsno datano data
Nancy Wyant
Senior Vice President of Development Operations2.08yrsno datano data

3.9yrs

Average Tenure

61yo

Average Age

Experienced Management: STOK's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Edward Kaye
CEO & Director5.33yrsUS$8.54m0.063%
$ 237.5k
Adrian Krainer
Co-Founder8.67yrsUS$378.03k1.03%
$ 3.8m
Seth Harrison
Independent Chairman of the Board7.58yrsUS$372.03k4.76%
$ 17.8m
Arthur Levin
Independent Director7.42yrsUS$340.53k0.046%
$ 170.8k
Garry Menzel
Independent Director2.5yrsUS$334.03k0%
$ 0
Muthiah Manoharan
Member of Scientific Advisory Board3.08yrsno datano data
Julie Smith
Independent Director2.67yrsUS$334.03k0%
$ 0
Jennifer Burstein
Independent Director3.67yrsUS$344.03k0%
$ 0
Arthur Tzianabos
Independent Director4.42yrsUS$346.53k0%
$ 0
Luca Cartegni
Member of Scientific Advisory Board3.08yrsno datano data
Juan Valcarcel
Member of Scientific Advisory Board3.08yrsno datano data

3.7yrs

Average Tenure

62yo

Average Age

Experienced Board: STOK's board of directors are considered experienced (3.7 years average tenure).